ICP Versus Intracranial Compliance Guided Management in SAH

University of Oslo (UIO)

Status: Completed

Conditions: Subarachnoid Hemorrhage (SAH)

Treatments: Device: ICP mean wave amplitude

Study type: Interventional

Funder types: Other

Identifiers

NCT00248690

S-05184

2005-SAHD

Details and patient eligibility

About

The purpose of this study is to determine whether treatment guided also by ICP mean wave amplitude improves outcome compared to international standard care in patients with SAH.

Full description

In this study SAH-patients are randomized to treatment based on international standard care (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy in addition to ICP/CPP guided therapy. Main outcome variables are survival and neurological outcome after 3 and 12 months.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subarachnoid hemorrhage, acute
• Intracerebral pressure monitoring device inserted

Exclusion criteria

• No intracranial pressure monitoring
• Age < 18 years